Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMEPROMAZINE: 3,024 Adverse Event Reports & Safety Profile

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain
3,024
Total FAERS Reports
585 (19.3%)
Deaths Reported
1,564
Hospitalizations
3,024
As Primary/Secondary Suspect
368
Life-Threatening
33
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status

FDA Application: 015865 ·

First Report: 1981 · Latest Report: 20250721

What Are the Most Common LEVOMEPROMAZINE Side Effects?

#1 Most Reported
Toxicity to various agents
324 reports (10.7%)
#2 Most Reported
Drug ineffective
307 reports (10.2%)
#3 Most Reported
Drug abuse
262 reports (8.7%)

All LEVOMEPROMAZINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Toxicity to various agents 324 10.7% 150 165
Drug ineffective 307 10.2% 4 203
Drug abuse 262 8.7% 84 82
Intentional overdose 217 7.2% 10 176
Somnolence 216 7.1% 4 159
Suicide attempt 210 6.9% 4 175
Off label use 184 6.1% 9 108
Intentional self-injury 162 5.4% 16 114
Overdose 142 4.7% 56 79
Drug interaction 129 4.3% 38 54
Suicidal ideation 128 4.2% 0 118
Electrocardiogram qt prolonged 123 4.1% 10 99
Coma 121 4.0% 11 81
Hypotension 121 4.0% 1 87
Neuroleptic malignant syndrome 118 3.9% 15 69
Condition aggravated 114 3.8% 1 93
Product use in unapproved indication 112 3.7% 4 68
Altered state of consciousness 111 3.7% 11 90
Fall 111 3.7% 8 73
Extrapyramidal disorder 101 3.3% 1 67

Who Reports LEVOMEPROMAZINE Side Effects? Age & Gender Data

Gender: 47.2% female, 52.8% male. Average age: 44.1 years. Most reports from: FR. View detailed demographics →

Is LEVOMEPROMAZINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 2 0 2
2004 3 1 0
2005 5 2 2
2006 5 0 3
2007 6 2 3
2008 7 3 2
2009 18 2 15
2010 6 1 4
2011 20 4 15
2012 44 23 18
2013 40 9 18
2014 80 7 45
2015 169 49 95
2016 161 16 113
2017 122 28 71
2018 217 38 140
2019 167 5 109
2020 142 11 94
2021 117 0 71
2022 118 16 51
2023 115 25 58
2024 116 17 66
2025 25 5 10

View full timeline →

What Is LEVOMEPROMAZINE Used For?

IndicationReports
Product used for unknown indication 1,250
Schizophrenia 324
Depression 202
Psychotic disorder 129
Bipolar disorder 85
Agitation 65
Schizoaffective disorder 59
Mental disorder 47
Insomnia 38
Drug abuse 37

LEVOMEPROMAZINE vs Alternatives: Which Is Safer?

LEVOMEPROMAZINE vs LEVOMETHADONE LEVOMEPROMAZINE vs LEVOMILNACIPRAN LEVOMEPROMAZINE vs LEVONORGESTREL LEVOMEPROMAZINE vs LEVORPHANOL LEVOMEPROMAZINE vs LEVOSIMENDAN LEVOMEPROMAZINE vs LEVOSULPIRIDE LEVOMEPROMAZINE vs LEVOTHYROXINE LEVOMEPROMAZINE vs LEVOTHYROXINE\LEVOTHYROXINE LEVOMEPROMAZINE vs LEVOTHYROXINE\LIOTHYRONINE LEVOMEPROMAZINE vs LEVOXYL

Official FDA Label for LEVOMEPROMAZINE

Official prescribing information from the FDA-approved drug label.